Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions – results from the European M2Spine study group - Takeaways - MDSpire

Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions – results from the European M2Spine study group

  • By

  • Vanessa Hubertus

  • Lennart Viezens

  • Martin Stangenberg

  • Anton M. Früh

  • Hanno S. Meyer

  • Raimunde Liang

  • Andreas Kramer

  • Christoph Orban

  • Johannes Kerschbaumer

  • Beate Kunze

  • Stefano Telera

  • Hannah Miller

  • Christian J. Entenmann

  • Emily J. von Bronewski

  • Charlotte Buhre

  • Leon-Gordian Leonhardt

  • Wolfgang Willenbacher

  • Irma Kvitsaridze

  • Dominik Laue

  • Matthias Pumberger

  • Theresa Keller

  • Güliz Acker

  • Jan Krönke

  • Igor-Wolfgang Blau

  • Ulrich Keller

  • Florian Ringel

  • Claudius Thomé

  • Bernhard Meyer

  • Peter Vajkoczy

  • Marc Dreimann

  • Julia Sophie Onken

  • June 13, 2025

  • 0 min

Share

  • 1

    Multiple Myeloma patients frequently experience bone-related complications, particularly from vertebral lesions, leading to significant morbidity.

  • 2

    Surgical intervention for vertebral lesions in MM patients is often avoided due to infection risks and the effectiveness of non-surgical treatments.

  • 3

    Cement augmentation can alleviate pain in MM patients but does not restore spinal stability or prevent deformities.

  • 4

    The European M2Spine study analyzed 704 MM patients to identify variations in surgical management and outcomes for vertebral lesions.

  • 5

    Current guidelines for surgical treatment of MM-related vertebral lesions are lacking, highlighting the need for standardized protocols.

Original Source(s)

Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions – results from the European M2Spine study group

  • by Vanessa Hubertus, Lennart Viezens, Martin Stangenberg, Anton M. Früh, Hanno S. Meyer, Raimunde Liang, Andreas Kramer, Christoph Orban, Johannes Kerschbaumer, Beate Kunze, Stefano Telera, Hannah Miller, Christian J. Entenmann, Emily J. von Bronewski, Charlotte Buhre, Leon-Gordian Leonhardt, Wolfgang Willenbacher, Irma Kvitsaridze, Dominik Laue, Matthias Pumberger, Theresa Keller, Güliz Acker, Jan Krönke, Igor-Wolfgang Blau, Ulrich Keller, Florian Ringel, Claudius Thomé, Bernhard Meyer, Peter Vajkoczy, Marc Dreimann, Julia Sophie Onken

  • June 13, 2025

Related Content

Dana-Farber Team Develops Open-Access Predictive Tool to Improve Monitoring of Smoldering Multiple Myeloma

The tool, called PANGEA-SMM, outperforms existing predictive tools by more accurately determining when smoldering multiple myeloma is progressing and requires treatment. The free online tool can be used immediately to monitor patients.

  • by

  • March 24, 2026

  • 5 min
Comparison of Dexmedetomidine and Midazolam-Fentanyl for Sedation and Analgesia During Surgery: A Systematic Review and Meta-Analysis

Evaluating Hypoalbuminemia as a Prognostic Indicator in Monoclonal Gammopathy of Undetermined Significance (MGUS) within Its Biological Framework